BMRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Biomerica Inc (BMRA) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, no significant positive catalysts, and declining financial performance. It is better to hold off on investing in this stock until stronger signals or improvements in financial and market conditions emerge.
The technical indicators for BMRA are weak. The MACD is below zero and negatively contracting, RSI is neutral at 41.378, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.272, with support at 2.155 and resistance at 2.389. Overall, the trend suggests a lack of bullish momentum.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress. The stock has a 60% chance of gaining 4.67% in the next week, but this is not a strong enough catalyst for a long-term investment.
The company's financial performance in Q2 2026 shows a revenue drop of -26.04% YoY and a gross margin decline of -84.24% YoY. Additionally, the stock's technical indicators and lack of significant trading trends suggest weak momentum.
In Q2 2026, Biomerica Inc reported declining revenue (-26.04% YoY) and gross margin (-84.24% YoY). However, net income improved by 38.95% YoY, and EPS increased slightly by 2.27% YoY. Despite these improvements, the overall financial performance remains weak.
No analyst rating or price target changes are available for BMRA. The lack of coverage indicates limited interest or confidence in the stock from the analyst community.
